MX2024013281A - Acido nucleico aislado que codifica una proteina de fusion basada en fviii-bdd y en un peptido se?al heterologo, y uso de la misma - Google Patents

Acido nucleico aislado que codifica una proteina de fusion basada en fviii-bdd y en un peptido se?al heterologo, y uso de la misma

Info

Publication number
MX2024013281A
MX2024013281A MX2024013281A MX2024013281A MX2024013281A MX 2024013281 A MX2024013281 A MX 2024013281A MX 2024013281 A MX2024013281 A MX 2024013281A MX 2024013281 A MX2024013281 A MX 2024013281A MX 2024013281 A MX2024013281 A MX 2024013281A
Authority
MX
Mexico
Prior art keywords
bdd
fviii
fusion protein
signal peptide
heterologous signal
Prior art date
Application number
MX2024013281A
Other languages
English (en)
Spanish (es)
Inventor
Mariya Pavlovna Perepelkina
Elena Veniaminovna Vlasova
Anastasiia Vladimirovna Fomina
Pavel Mikhailovich Gershovich
Vitaliia Aleksandrovna Markova
Dmitry Valentinovich Morozov
Original Assignee
Biocad Joint Stock Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU2022111695A external-priority patent/RU2818229C2/ru
Application filed by Biocad Joint Stock Co filed Critical Biocad Joint Stock Co
Publication of MX2024013281A publication Critical patent/MX2024013281A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2024013281A 2022-04-28 2024-10-28 Acido nucleico aislado que codifica una proteina de fusion basada en fviii-bdd y en un peptido se?al heterologo, y uso de la misma MX2024013281A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2022111695A RU2818229C2 (ru) 2022-04-28 Выделенная нуклеиновая кислота, которая кодирует слитый белок на основе FVIII-BDD и гетерологичного сигнального пептида, и ее применение
PCT/RU2023/050093 WO2023211315A1 (en) 2022-04-28 2023-04-18 Isolated nucleic acid that encodes fusion protein based on fviii-bdd and on heterologous signal peptide

Publications (1)

Publication Number Publication Date
MX2024013281A true MX2024013281A (es) 2024-12-06

Family

ID=88519415

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024013281A MX2024013281A (es) 2022-04-28 2024-10-28 Acido nucleico aislado que codifica una proteina de fusion basada en fviii-bdd y en un peptido se?al heterologo, y uso de la misma

Country Status (19)

Country Link
EP (1) EP4514975A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025515356A (cg-RX-API-DMAC7.html)
KR (1) KR20250005425A (cg-RX-API-DMAC7.html)
CN (1) CN117402901A (cg-RX-API-DMAC7.html)
AR (1) AR129164A1 (cg-RX-API-DMAC7.html)
AU (1) AU2023261711A1 (cg-RX-API-DMAC7.html)
CA (1) CA3250663A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024003295A1 (cg-RX-API-DMAC7.html)
CO (1) CO2024014703A2 (cg-RX-API-DMAC7.html)
CR (1) CR20240525A (cg-RX-API-DMAC7.html)
IL (1) IL316578A (cg-RX-API-DMAC7.html)
JO (1) JOP20240240A1 (cg-RX-API-DMAC7.html)
MA (1) MA68435A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024013281A (cg-RX-API-DMAC7.html)
PE (1) PE20251064A1 (cg-RX-API-DMAC7.html)
PY (1) PY2331055A (cg-RX-API-DMAC7.html)
TW (1) TW202342751A (cg-RX-API-DMAC7.html)
UY (1) UY40243A (cg-RX-API-DMAC7.html)
WO (1) WO2023211315A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120365434A (zh) * 2024-01-23 2025-07-25 上海苹谱医疗科技有限公司 一种提高凝血因子ⅷ分泌水平的双信号肽及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4382170A3 (en) * 2009-12-06 2024-09-04 Bioverativ Therapeutics Inc. Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof
EP2989208A4 (en) * 2013-04-22 2016-12-07 Catalent Pharma Solutions Llc DECORINAL COMPOSITIONS FOR VETERINARY MEDICINE AND USE THEREOF
RU2647769C2 (ru) * 2015-12-30 2018-03-19 Закрытое Акционерное Общество "Биокад" Химерный улучшенный рекомбинантный фактор VIII
KR20180118659A (ko) * 2016-02-01 2018-10-31 바이오버라티브 테라퓨틱스 인크. 최적화된 viii 인자 유전자
JP7357771B2 (ja) * 2019-09-03 2023-10-06 オソン メディカル イノベーション ファウンデーション タンパク質生産性の向上のための個別バーコーディングシステムを導入したシグナルペプチド超高速選別方法
WO2021084276A2 (en) * 2019-11-01 2021-05-06 Freeline Therapeutics Limited Factor viii construct

Also Published As

Publication number Publication date
PE20251064A1 (es) 2025-04-09
PY2331055A (es) 2023-12-05
AR129164A1 (es) 2024-07-24
IL316578A (en) 2024-12-01
CR20240525A (es) 2025-03-05
EP4514975A1 (en) 2025-03-05
CO2024014703A2 (es) 2024-12-30
JP2025515356A (ja) 2025-05-14
TW202342751A (zh) 2023-11-01
WO2023211315A1 (en) 2023-11-02
UY40243A (es) 2023-11-15
CN117402901A (zh) 2024-01-16
CA3250663A1 (en) 2023-11-02
AU2023261711A1 (en) 2024-11-21
JOP20240240A1 (ar) 2024-10-27
KR20250005425A (ko) 2025-01-09
MA68435A1 (fr) 2025-04-30
CL2024003295A1 (es) 2025-02-21

Similar Documents

Publication Publication Date Title
ES2177475T1 (es) Genes de corynebacterium glutamicum que codifican proteinas de una ruta metabolica.
DK0941318T3 (da) Håndvægtformede konstruerede ekspressionssystemer til genterapi
ATE486941T1 (de) Corynebacterium glutamicum gene, die für stoffwechselproteine kodieren
EP4663009A3 (en) Anthocyanin biosynthesis in carrot plants
Zhang et al. Enhanced secretion of human α1-antitrypsin expressed with a novel glycosylation module in tobacco BY-2 cell culture
CN109575116B (zh) 一种线粒体定位导肽及其发现方法与应用
ZA202501953B (en) Masking polypeptide, activatable novel prodrugs and methods of use thereof
CN102659928B (zh) 一种人工合成的信号肽及其应用
CN104066841A (zh) 表达载体和蛋白质的制造方法
CL2024003295A1 (es) Ácido nucleico aislado que codifica proteína de fusión basada en fviii-bdd y péptido señal heterólogo
Bröker et al. Expression of the human blood coagulation protein factor XIIIa in Saccharomyces cerevisiae: dependence of the expression levels from host-vector systems and medium conditions
US7056732B2 (en) Method for enhancing solubility of recombinant protein products in E. coli
AU647025B2 (en) Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification
JP2018514231A (ja) 増殖とタンパク質生成との分離
MX2024013280A (es) Acido nucleico de codon optimizado que codifica la proteina del factor viii de coagulacion de dominio b suprimido, y uso del mismo
CN103483423B (zh) 一种人工合成的信号肽及其应用
CN101921315B (zh) 一种人工合成的信号肽及其应用
WO2023114831A3 (en) Improvement of dnase1l3 serum half-life
JPH06311884A (ja) プラスミド及びそれで形質転換されたエ シェリチア・コリ
WO2022074182A9 (en) Method of producing a recombinant protein in a host cell which has a disabled rhamnose metabolism as well as expression vectors, host cells and recombinant proteins thereof
CN102659927B (zh) 一种人工合成的信号肽及其应用
KR102946862B1 (ko) 세포에서 바이오의약품을 생산하는 유전자 증폭시스템
CN104059128B (zh) 一种人工合成的信号肽及其应用
DK1629100T3 (da) Archaea-ekspressionssystem
WO2024010557A1 (en) Method for secretion of recombinant proteins from bacteria